ANTI-NOCICEPTIVE EFFECT OF AGRIMONIA EUPATORIA EXTRACT ON A CISPLATIN-INDUCED NEUROPATHIC MODEL by Lee, Keyong Ho & Rhee, Ki-Hyeong
Lee and Rhee et al., Afr J Tradit Complement Altern Med. (2016) 13(5):139-144 
doi:10.21010/ajtcam.v13i5.18 
139 
 
ANTI-NOCICEPTIVE EFFECT OF AGRIMONIA EUPATORIA EXTRACT ON A CISPLATIN-
INDUCED NEUROPATHIC MODEL 
 
Keyong Ho Lee1, Ki-Hyeong Rhee2 
 
1CKD Research Institute, Chong Kun Dang Pharm., Yongin, 449-797, Republic of Korea 
2College of Industrial Sciences, Kongju National University, Yesan 340-702, Republic of Korea 
 
Corresponding Author: K. H. Rhee, College of Industrial Sciences, Kongju National University, Yesan 340-
702, the republic of Korea. 
E-mail: howard@kongju.ac.kr 
 
 
Abstract 
 
Background: Natural products including Agrimonia eupatoria are considered an incomparable source of molecular diversity that 
has led to the medicines, especially for pain treatment. To investigate the antinociception of Agrimonia eupatoria, we examined its 
activity in a rat model of cisplatin neuropathy. 
Materials and Methods: Male Sprague-Dawley rats received intraperitoneal (i.p.) cisplatin twice a week at a dose of 2 mg/kg 
(cumulative dose, 20 mg/kg) for 4 weeks. Before each injection, 2 ml of sterile saline solution was given subcutaneously to prevent 
renal damage via hyperhydration. The mice were treated with gabapetin as a positive control drug with a 100mg/kg intraperitoneal 
injection. A. eupatoria extract of 200mg/kg was solved in saline and then treated by oral administration. 
Results: The mice treated with A. eupatoria showed lower withdrawal duration in the pin-prick and plantar tests, and a higher 
withdrawal threshold in the paw-withdrawal threshold test as compared to control animals in a cisplatin-induced neuropathic model. 
In the case of cold-allodynia, A. eupatoria treatment increased paw-withdrawal duration in a chemical test. A. eupatoria showed a 
more outstanding effect than gabapentin in all used tests for preventing cisplatin-induced nerve injury for 4 weeks. 
Conclusions: Our results suggest that A. eupatoria extract showed an antinociceptive effect in the pin-prick test, plantar test, and 
paw-withdrawal threshold test using a cisplatin-induced neuropathic rat model. 
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Introduction 
 
Pain is a common but distressing symptom of many diseases. In general, analgesics relieve pain by acting on the central 
nervous system or peripheral pain mechanisms, without significantly altering consciousness (Stewart et al., 2003). Patients suffering 
from this kind of pain include those with so-called nociceptive and neuropathic pain, allodynia, and hyperalgesia (Koltzenburg & 
Scadding, 2001; Woolf & Doubell, 1994). However, pain management remains a major clinical challenge, because there is not an 
appropriate understanding of the mechanisms causing and maintaining pain or effective treatments (Dickenson, 1991).Neuropathic 
pain is usually difficult to treat because its etiology is heterogeneous and the underlying pathophysiology is complex. The clinical 
features of neuropathic pain include the paradoxical combination of sensory loss in the neuropathic area suffering from pain and 
hypersensitivity phenomena such as allodynia and hyperalgesia (Bennett GJ, 1994). Because no universally efficacious therapy 
exists for these nociceptive signs, a better understanding of the mechanisms responsible for these nociceptive signs is required to 
develop more specific therapies. Among toxic neuropathies, those that are a consequence of certain chemotherapies (paclitaxel, 
vincristine, and cisplatin) frequently involve the development of painful sensory disorders and sometimes require the cessation of 
anticancer therapy (Airiau, 1999; Windebank, 1999). 
Cisplatin is used extensively in the treatment of cancers (testicular, ovarian, breast, bladder and lung), alone or in 
combination with another neurotoxic agent, paclitaxel, which is associated with serious adverse effects including nephrotoxicity and 
peripheral neurotoxicity. Renal toxicity is limited by chloride diuresis before, during, and after treatment. Sensory neuropathy, with 
complaints of paresthesiae and dysesthesiae in the distal extremities, is the major side effect (Krarup-Hansen et al., 1993). 
In animal studies, behavioural assessments have shown sensory (thermal hypoalgesia) and motor (coordination and motor 
force decrease) disorders after repeated injections of cisplatin in rats and mice (Authier et al., 2000). Numerous neurophysiologic 
studies have shown that cisplatin decreases sensory nerve conduction velocities and reduces the amplitude of nerve action potentials, 
with minimal or no motor involvement (Boyle et al., 1999).Cisplatin may be expected to accumulate in dorsal root ganglia, leading 
to nucleolar damage and an alteration in peptide content, and would also exert its neurotoxic effects through Schawnn cells 
(Yamamoto et al., 1997). Therefore, it is necessary to search for new, effective, and safe analgesics among natural products derived 
from secondary metabolites.  
The genus Agrimonia, belonging to the Rosaceae, include about a dozen species, which are perennial herbaceous 
flowering plants, mainly distributed in the temperate regions of the Northern Hemisphere. Some species have been used in 
traditional medicine, e.g. Agrimonia eupatoria has been traditionally used in Europe as an astringent, cholagogue, diuretic, and anti-
diabetic agent (Shabana et al., 2003), Agrimonia japonica has also been used in Japan as an antidiarrheal and a hemostatic agent 
(Okuda et al., 1984), and Agrimonia pilosa has been used in Traditional Chinese Medicine (TCM). The roots and aerial parts of A. 
pilosa have also had different usage in TCM. Roots have been used for the treatment of cancer, and tannins have been reported to be 
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principal constituents for this usage (Miyanoto et al., 1988). The aerial parts of A. pilosa were also listed in the Chinese 
Pharmacopoeia as an astringent hemostatic for treating various kinds of bleeding, including bloody dysentery, and also to counteract 
toxins and reduce swelling for treating boils and sores (Xu et al., 2005). Pharmacological studies on the extracts prepared from the 
aerial parts of A. pilosa demonstrated broad biological properties, such as anti-hemorrhagic (Wang et al., 1984), antiplatelet (Wang et 
al., 1985), antioxidant (Zhu et al., 2009), nitric oxide scavenging (Taira et al., 2009), acetylcholinesterase inhibition (Jung & Park, 
2007), and a-glucosidase inhibition (Liu et al., 2014)and antinociception (Park et al., 2012). Chemical studies on the aerial parts of A. 
pilosa showed the presence of flavonoids (Jung & Park, 2007), 3,4-dihydroisocoumarins (Taira et al., 2009), and triterpenoids (An et 
al., 2005). 
However, no studies have been made of the effect of A. eupatoria extracts on cisplatin-induced pain models, although the 
antinociceptive effect of A. pilosawas recently found in pain model. Therefore, the present study was designed to investigate whether 
A. eupatoria extracts exhibit antinociceptive effects on postoperative pain through various pain models including a cisplatin-induced 
model. 
 
 
Materials and Methods 
Animals 
 
Seventy-two male Sprague-Dawley rats (Slc, Shizuoka, Japan), weighing 180 to 200 g at the beginning of the experiment, 
were used and housed in plastic cages on a 12h light/12h dark cycle with access to water and food ad libitum. Room temperature was 
maintained at 22°C and relative humidity was usually between 50 and 60%. Animals were allowed a 1-week acclimatization period 
before use in experiments. All experimental procedures used in the present study were approved by the Ethics Committee of Kongju 
National University which has adopted the guidelines established by the National Institutes of Health and the ethical guidelines of 
the International Association for the Study of Pain. 
 
Test Sample 
 
The aerial part of A. eupatoria (500 g) was extracted with a volume of 80% ethanol equal to ten times that the sample of 
A. eupatoria used for 48h at room temperature, and then the extract was filtered and evaporated under reduced pressure. A test 
sample of 200mg/kg was solved in saline and then treated by oral administration. The aerial part of A. eupatoria was purchased from 
Jung Do Herb Co. Ltd (Seoul, Korea). A voucher specimen which was authenticized by one of the authors (Prof. K. H. Rhee) was 
deposited at the herbarium of the college of Industrial Sciences, Kongju National University, Korea. 
 
Cisplatin-Induced Neuropathic Pain Model 
 
Cisplatin (10 mg/20 mL, Laboratoires Qualimed Levallois-Perret, France) was diluted in normal saline (0.9% NaCl) just 
before administration to a final concentration between 0.08 and 0.15 mg/mL, depending on animal weight, while ensuring that 
volumes of less than 5 mL would be injected into the peritoneal cavity. Injected volumes of saline (0.9% NaCl) were calculated 
according to the weight of the ratin the control group. Cisplatin was administered intraperitoneally twice a week at a dose of 2 mg/kg 
(cumulative dose, 20 mg/kg) for 4 weeks. Before each injection, 2 mL of sterile saline solution was given subcutaneously to prevent 
renal damage via hyperhydration. Gabapetin as a positive control drug was administrated with a 100mg/kg intraperitoneal injection.  
 
Behavioral Assessment 
 
Pin-prick test, paw-pressure test, plantar test and chemical test were conducted before each injection of cisplatin. The 
guidelines of the IASP Committee for Research and Ethical Issues were followed for all experiments (Zimmermann, 1983). 
 
Pin-prick Test 
 
Mechanical hyperalgesia was assessed by pin-prick test: Touching (not penetrating) the skin with the point of a safety pin. 
The surface of the injured hind paw was touched with the point of a bent gauge needle (at 90° to the syringe) at intensity sufficient to 
produce a reflex withdrawal response. The paw withdrawal duration was recorded in seconds and the normal quick reflex withdrawal 
response was given the value of 0.5s (Nakamura et al., 1996). 
 
Paw-pressure Test 
 
Response to noxious mechanical stimulation was determined by measuring the withdrawal threshold to paw-pressure 
using an Analgesimeter (Orchid Scientifics & Innovatives, Nashik, India). Continuously increasing pressure was applied to the 
dorsal surface of the affected hind paw using the blunt conical probe in Randal Selitto test instrument. On the day before the 
experiment, nociceptive thresholds of the right or left hind paw of each rat were measured 4 times at 1h intervals. Mechanical 
pressure was increased until withdrawal reflex occurred while the rats were lightly restrained. Withdrawal reflex threshold were 
expressed in grams (Randall & Selitto, 1957). 
 
Plantar Test 
 
The Hargreaves method was used to assess paw-withdrawal duration to thermal nociceptive stimulus. The preoperative 
pain duration of the animals was recorded before surgery. Radiant heat was applied from below to the plantar surface ofeach hind-
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paw and the withdrawal duration was measured with a stop-watch. Three measurements were performed oneach hindpaw using a 
plantar test device from Orchid Scientifics & Innovatives with at least 1min intervals to determine mean paw-withdrawal duration 
(PWD). A preliminary or control paw withdrawal threshold was measured for each rat before drug injection. The cut-off value was 
determined as 30s in order to avoid tissue damage (Hargreaves et al., 1988). 
 
Chemical Test 
 
The rats were housed in transparent plastic boxes with a floor made of 6mm wire mesh. After a 5-10min accommodation 
period, 0.5 mL of acetone was sprayed onto the plantar surface of the rat’s hind leg from below the grid with a syringe with a blunt 
needle. Rats that developed cold allodynia withdrew the injured limb from the floor when acetone was applied, and the amount of 
time spent with the leg raised was used as a measure of pain. Both hind legs were tested in each animal, starting with the control leg, 
with an interval of 3min between them. The cut-off duration was determined to be 30s (Choi et al., 1994). 
 
Statistical Analysis 
 
Behavioural data were evaluated using analysis of variance (Fisher test) followed by Student’s t test to detect either 
differences within treatment groups between baseline and post injection values or differences between each treatment group on each 
day tested. Investigators performing the behavioral and histologic studies were blinded with respect to the treatment received by each 
group. 
 
 
Results  
Effect of A. Eupatoria Extract on Mechanical Hyperalgesia  
 
Cisplatin in rats induced neuropathic pain resulting in significant development of mechanical hyperalgesia in response to 
pin-prick stimulation and the application of pressure on the lateral surface of ipsilateral hindpaw. The paw-withdrawal duration to 
pin-prick significantly increased (p˂0.001) and the paw-withdrawal threshold to the application of pressure significantly decreased 
(p˂0.001) in the ipsilateral paw with the lapse of time. Treatment of cisplatin alone rapidly delayed the paw-withdrawal duration 
time as 6.24s at 1 week as compared to its duration time at 0 week of 0.89s, and then the paw-withdrawal duration time by cisplatin 
was increased gently to 8.22s by 4 week. The group treated with A. eupatoria extract of 200 mg/kg for 1 week showed an increase of 
duration time of4.5 times as compared to the7.0 times of the control group. Meanwhile, gabapentin also showed an increase of 
duration time of4.0 times as compared to 7.0 times of control group, it was a similar effect to A. eupatoria extract at 1 week. In the 
progress of time, the group of A. eupatoria extract maintains an inhibitory effect against increase of duration until the end of the 
experiment. In contrast gabapentin couldn’t prevent the increase of duration time as it showed a rapid increase from 4.52s to 8.09s 
from 2 week to 4 week. According to these data, A. eupatoria extract is better able to inhibit the increase of paw-withdrawal duration 
time than gabapentin during the experimental period. Treatment of cisplatin alone rapidly decreased the pressure value of the paw-
withdrawal threshold as much as 73g (from 241g to 168g) in the paw-withdrawal threshold at the point of 1 week and kept the value 
of 83g (from 241g to 158g) at the end of the experimental period. For improvement of the threshold value, A. eupatoria extract of 
200 mg/kg treated and inhibited the decrease of the threshold value as much as 47g (from 234g to 187g) at 1 week. In this case, 
gabapentin inhibited a decrease of the threshold value of24g (from 236g to 212g) at the same point. With the progress of time, the 
group treated with A. eupatoria extract showed a value of decreased paw-withdrawal threshold of47g at 1 week and kept the same 
value at the end of the experimental period. In contrast, gabapentin didn’t show a resistant activity of 95g which was increased from 
236g at 0 week to 141g at 4 week. From these data, A. eupatoria extract have the potential activity to improve the paw-withdrawal 
duration time and threshold as compared to gabapentin (Table 1 and 2). 
 
Table 1: Effect of A. eupatoria extracts on mechanical hyperalgesia using the pin-prick test on a cisplatin-induced pain models 
Treatment 
Paw-withdrawal Duration (sec) 
0 week 1 week 2 week 3 week 4 week 
Normal 0.86± 0.1 0.87± 0.2 0.90± 0.3 0.92± 0.1 0.90± 0.4 
Control 0.89± 0.2 6.24± 0.5 7.98± 0.6 8.23± 0.4 8.22± 0.5 
Gabapentin 0.91± 0.3 3.75± 0.3 4.52± 0.3 8.14± 0.3 8.09± 0.3 
A. eupatoria extract 0.84± 0.3 3.81± 0.2 3.74± 0.3 4.97± 0.4 5.37± 0.3 
Values are expressed Mean ± SEM, (n=6), p<0.05 compared to the control group. One way ANOVA followed by Tukey's Multiple 
Comparison Test. 
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Table 2: Effect of A. eupatoria extracts on mechanical hyperalgesia using the paw-withdrawal threshold test on a cisplatin-induced 
pain models 
Treatment 
Paw-withdrawal Threshold (g)  
0 week 1 week 2 week 3 week 4 week 
Normal 245± 17 237± 10 243± 20 241± 19 238± 21 
Control 241± 15 168± 14 162± 13 154± 11 158± 13 
Gabapentin 236± 19 212± 20 172± 15 143± 9 141± 15 
A. eupatoria extract 234± 18 187± 11 195± 13 193± 12 187± 10 
Values are expressed Mean ± SEM, (n=6), p<0.05 compared to the control group. One way ANOVA followed by Tukey's Multiple 
Comparison Test. 
 
 
Effect of A. Eupatoria Extract on Thermal Hyperalgesia 
 
The group treated with only cisplatin showed a significant increase in withdrawal latencies of 0.83s, 10.4s, 11.6s, 12.3s 
and 12.8s from 0 week to 4 weeks (p<0.05). A. eupatoria extract of 200mg/kg showed a significant increase in withdrawal latencies 
of 3.2s at 1 week. However it didn’t increase more than that until at the end of experiment. At the point of 1 week, the 
antihyperalgesia effect of A. eupatoria extract was 75%, compared to46% of gabapentin group. Those effects of both A. eupatoria 
extract and gabapentin were maintained until 4 week at 76% and 45%, respectively. However, A. eupatoria extract have shown 
superior antihyperalgesia activity when compared with gabapentin during the experimental period. Therefore, A. eupatoria extract 
has a greater potential to prevent thermal hyperalgesia by cisplatin than gabapentin (Table 3). 
 
 
 
Table 3: Effect of A. eupatoria extracts on thermal hyperalgesia using the plantar test on a cisplatin-induced pain models 
Treatment 
Paw-withdrawal Duration (sec)  
0 week 1 week 2 week 3 week 4 week 
Normal 0.81± 0.2 0.84± 0.1 0.84± 0.2 0.80± 0.3 0.81± 0.2 
Control 0.83± 0.3 10.4± 0.1 11.6± 0.3 12.3± 0.5 12.8± 0.3 
Gabapentin 0.87± 0.3 4.5± 0.1 5.1± 0.1 6.1± 0.1 7.4± 0.1 
A. eupatoria extract 0.84± 0.4 3.2± 0.3 3.5± 0.1 3.4± 0.1 3.7± 0.1 
Values are expressed Mean ± SEM, (n=6), p<0.05 compared to the control group. One way ANOVA followed by Tukey's Multiple 
Comparison Test. 
 
 
 
Effect of A. Eupatoria Extract on Cold-Allodynia Hyperalgesia 
 
The behavioral response to acetone in the cisplatin-induced neuropathic group as a control was significantly reduced as 
compared to the normal group (p<0.05). The withdrawal latencies of the control group gradually and significantly showed decreased 
values of 15.3s, 10.4s, 7.3s, 5.7s and 4.9s over the course of 4 weeks. The withdrawal latency time of the A. eupatoria extract group 
rapidly dropped from 15.7s to 11.8s at 1 week, however its latency times were kept constantly at from 11.8s to 10.8s after 1 week. In 
contrast, the gabapentin group showed a more serious decrease than that of A. eupatoria extract group. At 1 week, the 
antihyperalgesia effect of A. eupatoria extract was 20% as compared to 8% of gabapentin. At the end of the experiment, the 
antihyperalgesia effect of A. eupatoria extract was increased to 53%, compared to 18% of gabapentin. These results present a 
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potential antihyperalgesia effect of A. eupatoria extract to repair the neuropathic pain due to cisplatin (Table 4).  
 
 
Table 4: Effect of A. eupatoria extracts on cold-allodynia hyperalgesia using the chemical test on a cisplatin-induced pain models 
Treatment 
Paw-withdrawal Duration (sec)  
0 week 1 week 2 week 3 week 4 week 
Normal 16.2± 0.3 16.0± 0.1 15.8± 0.3 15.7± 0.1 16.3± 0.4 
Control 15.3± 0.4 10.4± 0.3 7.3± 0.1 5.7± 0.1 4.9± 0.2 
Gabapentin 16.0± 0.2 11.5± 0.2 10.5± 0.2 9.1± 0.2 7.5± 0.3 
A. eupatoria extract 15.7± 0.3 11.8± 0.2 10.8± 0.3 11.2± 0.3 10.8± 0.2 
Values are expressed Mean ± SEM, (n=6), p<0.05 compared to the control group. One way ANOVA followed by Tukey's Multiple 
Comparison Test. 
 
The cisplatin-induced neuropathic model is the representative animal model for inducing neuropathic pain. This model 
displays nociceptive signs such as a mechanical hyperalgesia and allodynia, a cold thermal hyperalgesia and allodynia, and a heat 
thermal hypoalgesia associated with significant electrophysiologic and histologic disorders (Authier et al., 2003).A major advantage 
of this model is persistent tactile allodynia. We used the pin-prick test and paw-withdrawal threshold test for mechanical 
hyperalgesia, and the plantar test for thermal hyperalgesia, and the chemical test for cold-allodynia in this study. According to 
various studies, such allodynia extended to at least 46 days by using cisplatin-induced mice. This persistency is in agreement with 
the dysaesthesia reported in the human chemotherapy patient (Authier et al., 2003; Krarup-Hansen et al., 2007; Ta et al., 2009).In the 
present study, we found that A. eupatoria extract produces antinociceptiive activity with various pain measure methods in cisplatin-
induced rats. Our results demonstrate that A. eupatoria displayed lower withdrawal duration in the pin-prick test and plantar test, and 
a higher withdrawal threshold in the paw-withdrawal threshold test as compared to control animals in cisplatin-induced neuropathic 
model. In case of cold-allodynia, A. eupatoria increased paw-withdrawal duration in the chemical test. The positive control drug, 
gabapentin, showed a lower effect than A. eupatoria in all used test for preventing cisplatin-induced nerve injury. This study showed 
a very similar result with another research group that found the antinociceptive activity of A. pilosa extract on the acetic acid-
induced writhing, tail-flick and hot-plate test (Park et al., 2012).A. eupatoria and A. pilosaare very similar herbs, even though they 
have been used differently and called by different names. A. eupatoria has been traditionally used in Europe as astringent, 
cholagogue, diuretic and antidiabetic agent (Shabana et al., 2003), and A. pilosahas been used for the treatment of cancer, and 
tannins were reported to be principal constituents for this usage (Miyanoto et al., 1988). Investigating each analytic component in 
methanol extract between A. eupatoria and A. pilosa, there are many common compounds, such as agrimony, agrimony lactone, 
tannin, flavonoids and glycosides. Therefore, this is the reason why A. eupatoria extract exhibited an antinociceptive effect that was 
similar to that of A. pilosa.Therefore, A. eupatoria extract has an antinociceptive effect in the neuropathic pain model, specifically, 
the chemotherapy-induced neuropathic pain model.   
 
Conclusion 
 
The findings of the present study demonstrate that A. eupatoria extract showed an antinociceptive property in a cisplatin-
induced neuropathic pain model. A. eupatoria extract showed lower withdrawal duration in the pin-prick test and plantar test, and a 
higher withdrawal threshold in the paw-withdrawal threshold test as compared to control animals in a cisplatin-induced neuropathic 
model. In case of cold-allodynia, A. eupatoria increased paw-withdrawal duration in the chemical test. A. eupatoria extract showed 
superior activity to gabapentin in all used test for preventing cisplatin-induced nerve injury. Therefore, A. eupatoria extract is found 
to possess therapeutic potential for the treatment of neuropathic pain. 
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